Loading…

Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome

Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G>C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-y...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinology, diabetes & metabolism case reports diabetes & metabolism case reports, 2022-02, Vol.2022 (1), p.1-5
Main Authors: Koivikko, Minna, Ebeling, Tapani, Mäkinen, Markus, Leppäluoto, Juhani, Raappana, Antti, Ahtiainen, Petteri, Salmela, Pasi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3
cites cdi_FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3
container_end_page 5
container_issue 1
container_start_page 1
container_title Endocrinology, diabetes & metabolism case reports
container_volume 2022
creator Koivikko, Minna
Ebeling, Tapani
Mäkinen, Markus
Leppäluoto, Juhani
Raappana, Antti
Ahtiainen, Petteri
Salmela, Pasi
description Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G>C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-year-old male with MEN1 syndrome, primary hyperparathyroidism and an acromegalic habitus was observed to have a pancreatic tumor on abdominal CT scanning, growth hormone (GH) and insulin-like growth factor 1 (IGF1) were elevated and plasma GHRH was exceptionally high. GHRH and GH were measured before the treatment and were followed during the study. During octreotide treatment, IGF1 normalized and the GH curve was near normal. After surgical treatment of primary hyperparathyroidism, a pancreatic tail tumor was enucleated. The tumor cells were positive for GHRH antibody staining. After the operation, acromegaly was cured as judged by laboratory tests. No reactivation of acromegaly has been seen during a 20-year follow-up. In conclusion, an ectopic GHRH-producing, pancreatic endocrine neoplasia may represent a rare manifestation of MEN1 syndrome. Learning points Clinical suspicion is in a key position in detecting acromegaly. Remember genetic disorders with young individuals having primary hyperparathyroidism. Consider multiple endocrine neoplasia type 1 syndrome when a person has several endocrine neoplasia. Acromegaly may be of ectopic origin with patients showing no abnormalities in radiological imaging of the pituitary gland.
doi_str_mv 10.1530/EDM-21-0079
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d21c70b53df44a2784d0774907d18994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d21c70b53df44a2784d0774907d18994</doaj_id><sourcerecordid>2632799267</sourcerecordid><originalsourceid>FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3</originalsourceid><addsrcrecordid>eNp9kc9rFDEUxwdRbKk9eZccBZman5PEg1Dq2i20CqLn8CbJrCkzyZrMCPvfm-22pb14Ssj75PNe8m2atwSfEcHwx9WXm5aSFmOpXzTHFAvaYiHZyyf7o-a0lFuMMcGCdYq9bo6YIFp3vDtuxnOb0-Q3MO6QhaV4h_odAnS5_rFutzm5xYa4QVuINnuYg0XRLzn56JLNIXo0L1PKn-qNDNmjCWIYfJkrmSJKA7pZfSOo7KLbd3nTvBpgLP70fj1pfn1d_bxYt9ffL68uzq_bnis9t12vHDDhFKZ0sJxybJWyPeFWKE00ACUaQ8-8Fhj33jrZWa2slJQ5x_TATpqrg9cluDXbHCbIO5MgmLuDlDcGcn3L6I2jxErcC-YGzoFKxR2WkmssHVFa8-r6fHBtl37yzvo4ZxifSZ9XYvhtNumvUUpLcSd4fy_I6c9S_8ZMoVg_jhB9WoqhHaNSa9rJin44oDWTUrIfHtsQbPZxmxq3ocTs4670u6eTPbIP4VaAHIA-pGJDnS8MwcJ_pf8A6CK1tw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2632799267</pqid></control><display><type>article</type><title>Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome</title><source>PubMed Central Free</source><creator>Koivikko, Minna ; Ebeling, Tapani ; Mäkinen, Markus ; Leppäluoto, Juhani ; Raappana, Antti ; Ahtiainen, Petteri ; Salmela, Pasi</creator><creatorcontrib>Koivikko, Minna ; Ebeling, Tapani ; Mäkinen, Markus ; Leppäluoto, Juhani ; Raappana, Antti ; Ahtiainen, Petteri ; Salmela, Pasi</creatorcontrib><description>Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G&gt;C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-year-old male with MEN1 syndrome, primary hyperparathyroidism and an acromegalic habitus was observed to have a pancreatic tumor on abdominal CT scanning, growth hormone (GH) and insulin-like growth factor 1 (IGF1) were elevated and plasma GHRH was exceptionally high. GHRH and GH were measured before the treatment and were followed during the study. During octreotide treatment, IGF1 normalized and the GH curve was near normal. After surgical treatment of primary hyperparathyroidism, a pancreatic tail tumor was enucleated. The tumor cells were positive for GHRH antibody staining. After the operation, acromegaly was cured as judged by laboratory tests. No reactivation of acromegaly has been seen during a 20-year follow-up. In conclusion, an ectopic GHRH-producing, pancreatic endocrine neoplasia may represent a rare manifestation of MEN1 syndrome. Learning points Clinical suspicion is in a key position in detecting acromegaly. Remember genetic disorders with young individuals having primary hyperparathyroidism. Consider multiple endocrine neoplasia type 1 syndrome when a person has several endocrine neoplasia. Acromegaly may be of ectopic origin with patients showing no abnormalities in radiological imaging of the pituitary gland.</description><identifier>ISSN: 2052-0573</identifier><identifier>EISSN: 2052-0573</identifier><identifier>DOI: 10.1530/EDM-21-0079</identifier><identifier>PMID: 35199646</identifier><language>eng</language><publisher>England: Bioscientifica Ltd</publisher><subject>Adult ; Finland ; Gastroenterology ; General Practice ; Genetics ; Insight into Disease Pathogenesis or Mechanism of Therapy ; Male ; Neuroendocrinology ; Pancreas ; Tumours and Neoplasia ; White</subject><ispartof>Endocrinology, diabetes &amp; metabolism case reports, 2022-02, Vol.2022 (1), p.1-5</ispartof><rights>The authors</rights><rights>The authors 2022 The authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3</citedby><cites>FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3</cites><orcidid>0000-0001-7227-966X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897594/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897594/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35199646$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koivikko, Minna</creatorcontrib><creatorcontrib>Ebeling, Tapani</creatorcontrib><creatorcontrib>Mäkinen, Markus</creatorcontrib><creatorcontrib>Leppäluoto, Juhani</creatorcontrib><creatorcontrib>Raappana, Antti</creatorcontrib><creatorcontrib>Ahtiainen, Petteri</creatorcontrib><creatorcontrib>Salmela, Pasi</creatorcontrib><title>Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome</title><title>Endocrinology, diabetes &amp; metabolism case reports</title><addtitle>Endocrinol Diabetes Metab Case Rep</addtitle><description>Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G&gt;C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-year-old male with MEN1 syndrome, primary hyperparathyroidism and an acromegalic habitus was observed to have a pancreatic tumor on abdominal CT scanning, growth hormone (GH) and insulin-like growth factor 1 (IGF1) were elevated and plasma GHRH was exceptionally high. GHRH and GH were measured before the treatment and were followed during the study. During octreotide treatment, IGF1 normalized and the GH curve was near normal. After surgical treatment of primary hyperparathyroidism, a pancreatic tail tumor was enucleated. The tumor cells were positive for GHRH antibody staining. After the operation, acromegaly was cured as judged by laboratory tests. No reactivation of acromegaly has been seen during a 20-year follow-up. In conclusion, an ectopic GHRH-producing, pancreatic endocrine neoplasia may represent a rare manifestation of MEN1 syndrome. Learning points Clinical suspicion is in a key position in detecting acromegaly. Remember genetic disorders with young individuals having primary hyperparathyroidism. Consider multiple endocrine neoplasia type 1 syndrome when a person has several endocrine neoplasia. Acromegaly may be of ectopic origin with patients showing no abnormalities in radiological imaging of the pituitary gland.</description><subject>Adult</subject><subject>Finland</subject><subject>Gastroenterology</subject><subject>General Practice</subject><subject>Genetics</subject><subject>Insight into Disease Pathogenesis or Mechanism of Therapy</subject><subject>Male</subject><subject>Neuroendocrinology</subject><subject>Pancreas</subject><subject>Tumours and Neoplasia</subject><subject>White</subject><issn>2052-0573</issn><issn>2052-0573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kc9rFDEUxwdRbKk9eZccBZman5PEg1Dq2i20CqLn8CbJrCkzyZrMCPvfm-22pb14Ssj75PNe8m2atwSfEcHwx9WXm5aSFmOpXzTHFAvaYiHZyyf7o-a0lFuMMcGCdYq9bo6YIFp3vDtuxnOb0-Q3MO6QhaV4h_odAnS5_rFutzm5xYa4QVuINnuYg0XRLzn56JLNIXo0L1PKn-qNDNmjCWIYfJkrmSJKA7pZfSOo7KLbd3nTvBpgLP70fj1pfn1d_bxYt9ffL68uzq_bnis9t12vHDDhFKZ0sJxybJWyPeFWKE00ACUaQ8-8Fhj33jrZWa2slJQ5x_TATpqrg9cluDXbHCbIO5MgmLuDlDcGcn3L6I2jxErcC-YGzoFKxR2WkmssHVFa8-r6fHBtl37yzvo4ZxifSZ9XYvhtNumvUUpLcSd4fy_I6c9S_8ZMoVg_jhB9WoqhHaNSa9rJin44oDWTUrIfHtsQbPZxmxq3ocTs4670u6eTPbIP4VaAHIA-pGJDnS8MwcJ_pf8A6CK1tw</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Koivikko, Minna</creator><creator>Ebeling, Tapani</creator><creator>Mäkinen, Markus</creator><creator>Leppäluoto, Juhani</creator><creator>Raappana, Antti</creator><creator>Ahtiainen, Petteri</creator><creator>Salmela, Pasi</creator><general>Bioscientifica Ltd</general><general>Bioscientifica</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7227-966X</orcidid></search><sort><creationdate>20220201</creationdate><title>Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome</title><author>Koivikko, Minna ; Ebeling, Tapani ; Mäkinen, Markus ; Leppäluoto, Juhani ; Raappana, Antti ; Ahtiainen, Petteri ; Salmela, Pasi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Finland</topic><topic>Gastroenterology</topic><topic>General Practice</topic><topic>Genetics</topic><topic>Insight into Disease Pathogenesis or Mechanism of Therapy</topic><topic>Male</topic><topic>Neuroendocrinology</topic><topic>Pancreas</topic><topic>Tumours and Neoplasia</topic><topic>White</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koivikko, Minna</creatorcontrib><creatorcontrib>Ebeling, Tapani</creatorcontrib><creatorcontrib>Mäkinen, Markus</creatorcontrib><creatorcontrib>Leppäluoto, Juhani</creatorcontrib><creatorcontrib>Raappana, Antti</creatorcontrib><creatorcontrib>Ahtiainen, Petteri</creatorcontrib><creatorcontrib>Salmela, Pasi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Endocrinology, diabetes &amp; metabolism case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koivikko, Minna</au><au>Ebeling, Tapani</au><au>Mäkinen, Markus</au><au>Leppäluoto, Juhani</au><au>Raappana, Antti</au><au>Ahtiainen, Petteri</au><au>Salmela, Pasi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome</atitle><jtitle>Endocrinology, diabetes &amp; metabolism case reports</jtitle><addtitle>Endocrinol Diabetes Metab Case Rep</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>2022</volume><issue>1</issue><spage>1</spage><epage>5</epage><pages>1-5</pages><issn>2052-0573</issn><eissn>2052-0573</eissn><abstract>Summary Multiple endocrine neoplasia type 1 NM_001370259.2(MEN1):c.466G&gt;C(p.Gly156Arg) is characterized by tumors of various endocrine organs. We report on a rare, growth hormone-releasing hormone (GHRH)-releasing pancreatic tumor in a MEN1 patient with a long-term follow-up after surgery. A 22-year-old male with MEN1 syndrome, primary hyperparathyroidism and an acromegalic habitus was observed to have a pancreatic tumor on abdominal CT scanning, growth hormone (GH) and insulin-like growth factor 1 (IGF1) were elevated and plasma GHRH was exceptionally high. GHRH and GH were measured before the treatment and were followed during the study. During octreotide treatment, IGF1 normalized and the GH curve was near normal. After surgical treatment of primary hyperparathyroidism, a pancreatic tail tumor was enucleated. The tumor cells were positive for GHRH antibody staining. After the operation, acromegaly was cured as judged by laboratory tests. No reactivation of acromegaly has been seen during a 20-year follow-up. In conclusion, an ectopic GHRH-producing, pancreatic endocrine neoplasia may represent a rare manifestation of MEN1 syndrome. Learning points Clinical suspicion is in a key position in detecting acromegaly. Remember genetic disorders with young individuals having primary hyperparathyroidism. Consider multiple endocrine neoplasia type 1 syndrome when a person has several endocrine neoplasia. Acromegaly may be of ectopic origin with patients showing no abnormalities in radiological imaging of the pituitary gland.</abstract><cop>England</cop><pub>Bioscientifica Ltd</pub><pmid>35199646</pmid><doi>10.1530/EDM-21-0079</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-7227-966X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2052-0573
ispartof Endocrinology, diabetes & metabolism case reports, 2022-02, Vol.2022 (1), p.1-5
issn 2052-0573
2052-0573
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_d21c70b53df44a2784d0774907d18994
source PubMed Central Free
subjects Adult
Finland
Gastroenterology
General Practice
Genetics
Insight into Disease Pathogenesis or Mechanism of Therapy
Male
Neuroendocrinology
Pancreas
Tumours and Neoplasia
White
title Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A28%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acromegaly%20caused%20by%20a%20GHRH-producing%20pancreatic%20neuroendocrine%20tumor:%20a%20rare%20manifestation%20of%20MEN1%20syndrome&rft.jtitle=Endocrinology,%20diabetes%20&%20metabolism%20case%20reports&rft.au=Koivikko,%20Minna&rft.date=2022-02-01&rft.volume=2022&rft.issue=1&rft.spage=1&rft.epage=5&rft.pages=1-5&rft.issn=2052-0573&rft.eissn=2052-0573&rft_id=info:doi/10.1530/EDM-21-0079&rft_dat=%3Cproquest_doaj_%3E2632799267%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b489t-6b8da35d8022fc4240c88cb14c58919aa2190ab3e9500becd76c98c7723dd39f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2632799267&rft_id=info:pmid/35199646&rfr_iscdi=true